United States · FDA National Drug Code directory
Everolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51991-990_fade73fb-a367-4c53-83dd-1352c3ad807b
- Product NDC
- 51991-990
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- Everolimus
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250128
- Source listing expiry
- 20261231
Source-listed ingredients
- EVEROLIMUS — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (51991-990-28) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (51991-990-99) · 51991-990-28
- 28 TABLET, FOR SUSPENSION in 1 BOTTLE (51991-990-77) · 51991-990-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →